1 |
Shirley LA, Jones NB, Phay JE. The role of central neck lymph node dissection in the management of papillary thyroid cancer [J]. Front Oncol, 2017, 7: 122.
|
2 |
冯尚勇, 刘超. 美国甲状腺协会《甲状腺髓样癌修订版指南》解读 [J]. 中华内分泌代谢杂志, 2016, 32(5): 356-360.
|
3 |
Pelizzo MR, Boschin IM, Bernante P, et al. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients [J]. Eur J Surg Oncol, 2007, 33(4): 493-497.
|
4 |
Polistena A, Sanguinetti A, Lucchini R, et al. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: a case series from a single institution [J]. Int J Surg, 2017, 41 Suppl 1: S70-S74.
|
5 |
Woliński K, Rewaj-Łosyk M, Ruchała M. Sonographic features of medullary thyroid carcinomas--a systematic review and meta-analysis [J]. Endokrynol Pol, 2014, 65(4): 314-318.
|
6 |
Esfandiari NH, Hughes DT, Yin H, et al. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer [J]. J Clin Endocrinol Metab, 2014, 99(2): 448-454.
|
7 |
Niederle B. Screening for medullary carcinoma of the thyroid [J]. Br J Surg, 2014, 101(13): 1625-1626.
|
8 |
Panigrahi B, Roman SA, Sosa JA. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines? [J]. Ann Surg Oncol, 2010, 17(6): 1490-1498.
|
9 |
Treglia G, Aktolun C, Chiti A, et al. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine [J]. Eur J Nucl Med Mol Imaging, 2016, 43(8): 1486-1490.
|
10 |
蔡胜, 欧阳云淑, 李建初, 等. 超声对甲状腺髓样癌的诊断价值 [J]. 中国超声医学杂志, 2008, 24(12): 1071-1075.
|
11 |
Lee JH, Shin JH, Lee HW, et al. Sonographic and cytopathologic correlation of papillary thyroid carcinoma variants [J]. J Ultrasound Med, 2015, 34(1): 1-15.
|
12 |
Cappelli C, Castellano M, Pirola I, et al. Thyroid nodule shape suggests malignancy [J]. Eur J Endocrinol, 2006, 155(1): 27-31.
|
13 |
Kim SH, Kim BS, Jung SL, et al. Ultrasonographic findings of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma [J]. Korean J Radiol, 2009, 10(2): 101-105.
|
14 |
Cho KE, Gweon HM, Park AY, et al. Ultrasonographic features of medullary thyroid carcinoma: do they correlate with pre and postoperative calcitonin levels? [J]. Asian Pac J Cancer Prev, 2016, 17(7): 3357-3362.
|
15 |
王满立, 李妙珊, 冯占武, 等. 甲状腺髓样癌超声特征与病理结果对比分析 [J]. 实用医学杂志, 2015, 31(5): 799-801.
|
16 |
Foschini MP, Ragazzi M, Parmeggiani AL, et al. Comparison between echo-color Doppler sonography features and angioarchitecture of thyroid nodules [J]. Int J Surg Pathol, 2007, 15(2): 135-142.
|
17 |
计静丹, 詹维伟, 徐上研. 彩色多普勒超声鉴别甲状腺结节良恶性价值的再探讨 [J/CD]. 中华医学超声杂志(电子版), 2011, 8(6): 1289-1295.
|
18 |
Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection [J]. Ann Surg, 229(6): 880-887. discussion 887-888.
|
19 |
Elisei R, Bottici V, Luchetti F, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders [J]. J Clin Endocrinol Metab, 2004, 89(1): 163-168.
|
20 |
Ceolin L, MADS Duval, Benini AF, et al. Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives [J]. Endocr Relat Cancer, 2019, 26(9): R499-R518.
|
21 |
中华医学会内分泌学分会, 中华医学会外科学分会, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中国肿瘤临床, 2012, 39(17): 1249-1272.
|